Miami Lakes, FLNCT07459647Now EnrollingIRB Ready

Schizophrenia Clinical Trial in Miami Lakes, FL

Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Miami Lakes. Study-provided care at no cost to qualified participants.

Sponsored by MapLight Therapeutics

Quick Self-Assessment

See if you qualify for this Miami Lakes location

Preparing your pre-screening questions…

Expert Care in Miami Lakes

Access schizophrenia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related schizophrenia treatment provided free

Apply for This Miami Lakes Location

Check if you qualify for this schizophrenia clinical trial in Miami Lakes, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Miami Lakes

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Miami Lakes site if eligible
  4. 4Begin participation

About This Schizophrenia Study in Miami Lakes

ML-007C-MA-212 is a 52-week open-label study designed to evaluate the long-term safety, tolerability, and effectiveness of ML-007C-MA in participants with schizophrenia who have recently completed an antecedent study (ML-007C-MA-211) or enroll directly (De Novo Cohort).

Sponsor: MapLight Therapeutics

Who Can Participate

Inclusion Criteria

Must be able and willing to provide informed consent for all required study procedures.
Has a primary diagnosis of schizophrenia based on the DSM-5 criteria that is confirmed by semi-structured clinical interview (Mini International Neuropsychiatric Interview for DSM-5).
May benefit from long-term pharmacotherapy for schizophrenia, based on assessment of the investigator.
Is appropriate for an outpatient level of care and resides in a stable living situation, based on assessment of the investigator.
Has an identified reliable informant(s) available to participate in relevant assessments. Site staff may serve as the informant if the site has had regular contact with the participant for \>1 year. Key

Exclusion Criteria

Has any DSM-5 disorder, other than schizophrenia, within the 12 months before Screening that is primarily responsible for the current symptoms or functional impairment.
Is discontinuing effective and well-tolerated antipsychotic therapy for the purpose of enrolling in this study.
Has received any prohibited therapy within the Screening Period unless discontinued before Baseline.
Has current evidence of a clinically significant and/or unstable medical comorbidity at Screening or Baseline.
Has clinically significant abnormal physical examination, ECG, or clinical safety laboratory result at Screening or Baseline.
Has an elevated risk of suicidal behavior.
Has a known allergy to ML-007C-MA, its active ingredients or their excipients.
Has a DSM-5 diagnosis of moderate to severe substance use disorder (except tobacco or caffeine use disorder) within the 12 months before Screening (confirmed using MINI version 7.0.2 at Screening).
Has an elevated risk of violent or destructive behavior, based on participant history and investigator judgment.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Miami Lakes?

Yes, this clinical trial (NCT07459647) has an active research site in Miami Lakes, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Schizophrenia Treatment Options in Miami Lakes, FL

If you're searching for schizophrenia treatment options in Miami Lakes, FL, this clinical trial (NCT07459647) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Miami Lakes research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all schizophrenia clinical trials near you to find additional studies recruiting in your area.

More Schizophrenia Trials in Miami Lakes, FL

See all schizophrenia clinical trials recruiting in Miami Lakes — not just this study.

Browse Schizophrenia Trials in Miami Lakes →

Browse More Trials by Condition

Schizophrenia TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Miami Lakes?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Miami Lakes, FL